International journal of dermatology · 2005
Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ray Carolyn M, Kluk Michael, Grin Caron M, Grant-Kels Jane M
Аннотация
BACKGROUND: Current treatment recommendations for malignant melanoma in situ include surgical excision with at least 0.5 cm margins. On the head or neck, obtaining adequate surgical margins for melanoma can be challenging and often disfiguring. In addition, some elderly patients may not be good surgical candidates and may request less aggressive interventions.
METHODS: We report herein three cases of malignant melanoma in situ on the face treated with topical imiquimod cream.
RESULTS: Complete regression of malignant melanoma in situ was observed on treatment with 5% topical imiquimod cream. The varied treatment regimens, rationale for using imiquimod rather than performing surgery, and the possible mechanisms of action are discussed.
CONCLUSIONS: Topical imiquimod can be used successfully for the treatment of malignant melanoma in situ on the face.
METHODS: We report herein three cases of malignant melanoma in situ on the face treated with topical imiquimod cream.
RESULTS: Complete regression of malignant melanoma in situ was observed on treatment with 5% topical imiquimod cream. The varied treatment regimens, rationale for using imiquimod rather than performing surgery, and the possible mechanisms of action are discussed.
CONCLUSIONS: Topical imiquimod can be used successfully for the treatment of malignant melanoma in situ on the face.